Provenienza dei contatti di primo grado di Lars Bruce
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018.
3
| Private Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Lars Bruce tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree | |
Abarceo AB
 Abarceo AB Miscellaneous Commercial ServicesCommercial Services Abarceo AB develops novel therapeutics for type-2 diabetes. It identifies a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic treatment to revert beta cells from dysfunctional to functional, preserving beta cell function and allowing patients to produce insulin naturally. The company was founded by Tara Heitner, Claes Wollheim, and Albert Salehi in December 2017 and is headquartered in Malmo, Sweden. | Miscellaneous Commercial Services | Founder | |
| CYXONE AB | Pharmaceuticals: Major | Chief Executive Officer | |
| McGill University | College/University | Doctorate Degree | |
| Technical University of Denmark | College/University | Masters Business Admin | |
| Heitner Biopharm Consultation | Founder | ||
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Biotechnology | Chief Executive Officer | |
| Nordic Pharma Licensing Group | Director/Board Member | ||
| Bainan Biotech | Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 5 |
| Danimarca | 5 |
| Regno Unito | 2 |
| Canada | 2 |
| Germania | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 7 |
| Founder | 4 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Lars Bruce
- Connessioni Società
